Investigations Into the Outbreak of Chandipura Virus Encephalitis, Gujarat, India, 2024

Chandipura virus, a Vesiculovirus, was first identified in India during an outbreak investigation of acute febrile illness in 1965. The virus first gained global attention after being implicated as the causative agent of an outbreak of acute viral encephalitis characterized by rapid clinical deterioration and death, in 2003. Since then, the virus has caused multiple outbreaks in central and western Indian states. During July 2024, an increased incidence of acute encephalitis was reported from Gujarat state. In response an outbreak investigation was carried out and Chandipura virus was identified as the major etiology, accounting for 23.45% of the cases. Clinically, the disease was characterized by rapid progression of illness, with total duration of illness ranging from 24 to 72 h in majority of the cases. Vomiting was found to be significantly more in cases of Chandipura viral encephalitis. In the current outbreak, multiorgan dysfunction was identified as a complication in Chandipura infections. Serum glutamic-pyruvic transaminase and creatinine were found to be significantly elevated in cases of Chandipura encephalitis, compared to other etiologies of acute viral encephalitis. The case fatality rate in the current outbreak was 47.36%. Among the samples collected during the investigations, 69% humans and 8.76% animal samples tested positive for neutralizing antibodies against Chandipura virus. Fever surveillance during the outbreak also identified Chandipura IgM positive cases without neurological involvement, raising the possibility of Chandipura febrile illness. Phylogenetic analysis of the isolate from 2024 indicates similarity with isolates obtained during 2012 and 2014 from Gujarat.

Authors

Institutions

Publication Details

Journal
Journal of Medical Virology
Published
2025-06-24
DOI
https://doi.org/10.1002/jmv.70456
Citations
1
Primary Topic
Virology and Viral Diseases
Type
article
Field-Weighted Citation Impact
1.35
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Investigations Into the Outbreak of Chandipura Virus Encephalitis, Gujarat, India, 2024

Daya V. Pavitrakar, Pradeep Sawant, S.A. Mahamuni, Suneela Garg et al.
1 citations
Journal of Medical Virology
Virology and Viral Diseases
1.35
article

Investigations Into the Outbreak of Chandipura Virus Encephalitis, Gujarat, India, 2024

Daya V. Pavitrakar, Pradeep Sawant, S.A. Mahamuni, Suneela Garg, C. Balachandran, Kamlesh J. Upadhyay, Irrusappan Hari, Dilip Patil, Manisha Tupekar, Anisha Pulinchani, Datta K. Butte, P Saxena, Vijay P. Bondre, Padinjaremattathil Thankappan Ullas, Naveen Kumar, Amit Kanani, Snehal P. Chavhan, Avinash R. Deoshatwar, Yash Sharma, Kunal Sakhare, Surendra Kumar, S K Shankar, S. K. Sharma, Jayesh M. Katira, Kiran Dattu Waghale, Shraddha Ratnakar, Prafulla Sonowane, Sachin Dhaygude
article en
1 citations

Abstract

Chandipura virus, a Vesiculovirus, was first identified in India during an outbreak investigation of acute febrile illness in 1965. The virus first gained global attention after being implicated as the causative agent of an outbreak of acute viral encephalitis characterized by rapid clinical deterioration and death, in 2003. Since then, the virus has caused multiple outbreaks in central and western Indian states. During July 2024, an increased incidence of acute encephalitis was reported from Gujarat state. In response an outbreak investigation was carried out and Chandipura virus was identified as the major etiology, accounting for 23.45% of the cases. Clinically, the disease was characterized by rapid progression of illness, with total duration of illness ranging from 24 to 72 h in majority of the cases. Vomiting was found to be significantly more in cases of Chandipura viral encephalitis. In the current outbreak, multiorgan dysfunction was identified as a complication in Chandipura infections. Serum glutamic-pyruvic transaminase and creatinine were found to be significantly elevated in cases of Chandipura encephalitis, compared to other etiologies of acute viral encephalitis. The case fatality rate in the current outbreak was 47.36%. Among the samples collected during the investigations, 69% humans and 8.76% animal samples tested positive for neutralizing antibodies against Chandipura virus. Fever surveillance during the outbreak also identified Chandipura IgM positive cases without neurological involvement, raising the possibility of Chandipura febrile illness. Phylogenetic analysis of the isolate from 2024 indicates similarity with isolates obtained during 2012 and 2014 from Gujarat.

Journal of Medical VirologyVol. 97(7)
Rajendra Memorial Research Institute of Medical Sciences (IN), Government of Gujarat (IN), Indian Council of Medical Research (IN), ICMR-National Institute of Virology (IN), B.J. Medical College (IN)
Good health and well-being
Openalex Percentile: Top 18%
Virology and Viral Diseases
1.35
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.